Lumeran, Jerald Kurt D.

HRN: 21-74-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
07/25/2025
07/31/2025
PO
5mL
BID X3days
Ascaris
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines